BRPI0510427A - uso de inibidores da proteìna de choque térmico para a reduçaõ do crescimento de pêlos - Google Patents

uso de inibidores da proteìna de choque térmico para a reduçaõ do crescimento de pêlos

Info

Publication number
BRPI0510427A
BRPI0510427A BRPI0510427-0A BRPI0510427A BRPI0510427A BR PI0510427 A BRPI0510427 A BR PI0510427A BR PI0510427 A BRPI0510427 A BR PI0510427A BR PI0510427 A BRPI0510427 A BR PI0510427A
Authority
BR
Brazil
Prior art keywords
hair growth
shock protein
heat shock
protein inhibitors
growth reduction
Prior art date
Application number
BRPI0510427-0A
Other languages
English (en)
Inventor
Natalia Botchkareva
Gurpreet S Ahluwalia
Douglas Shander
Original Assignee
Gillette Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gillette Co filed Critical Gillette Co
Publication of BRPI0510427A publication Critical patent/BRPI0510427A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

USO DE INIBIDORES DA PROTEìNA DE CHOQUE TéRMICO PARA A REDUçãO DO CRESIMENTO DE PêLOS. O crescimento de cabelos ou pêlos em mamíferos é reduzido mediante a aplicação tópica de uma composição que inclui um inibidor da proteína de choque térmico.
BRPI0510427-0A 2004-04-27 2005-04-25 uso de inibidores da proteìna de choque térmico para a reduçaõ do crescimento de pêlos BRPI0510427A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/833,673 US20050249685A1 (en) 2004-04-27 2004-04-27 Reduction of hair growth
PCT/US2005/014273 WO2005105023A1 (en) 2004-04-27 2005-04-25 Use of heat shock protein inhibitorsfor the reduction of hair growth

Publications (1)

Publication Number Publication Date
BRPI0510427A true BRPI0510427A (pt) 2008-01-02

Family

ID=34967210

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510427-0A BRPI0510427A (pt) 2004-04-27 2005-04-25 uso de inibidores da proteìna de choque térmico para a reduçaõ do crescimento de pêlos

Country Status (10)

Country Link
US (2) US20050249685A1 (pt)
EP (1) EP1750653A1 (pt)
JP (1) JP4189024B2 (pt)
KR (2) KR100891884B1 (pt)
CN (1) CN1946372B (pt)
AU (1) AU2005237545B2 (pt)
BR (1) BRPI0510427A (pt)
CA (1) CA2563193A1 (pt)
MX (1) MXPA06012400A (pt)
WO (1) WO2005105023A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006069259A2 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
US20070059264A1 (en) * 2005-09-13 2007-03-15 Ahluwalia Gurpreet S Reduction of hair growth
US7727516B2 (en) 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
JP2009132622A (ja) * 2006-03-20 2009-06-18 Kaneka Corp 神経突起伸長誘導剤
JP5654808B2 (ja) * 2010-09-09 2015-01-14 花王株式会社 毛成長制御剤の評価又は選択方法
CN103118661B (zh) * 2010-09-09 2017-09-22 花王株式会社 毛发生长控制方法、毛发生长控制剂的评价或选择方法、以及毛发生长抑制剂

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426137A (en) * 1965-12-23 1969-02-04 Olin Mathieson Hair growth inhibiting by aminobenzophenones
US4161540A (en) * 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
JPS5432773B2 (pt) * 1972-05-09 1979-10-16
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4201873A (en) * 1975-09-17 1980-05-06 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD2 analogs
US4203924A (en) * 1976-01-08 1980-05-20 The Upjohn Company 2-Decarboxy-2-hydroxymethyl-deoxy-9,10-didehydro-PGD2 analogs
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
FR2380775A1 (fr) * 1977-02-22 1978-09-15 Sederma Sarl Composition " apres-epilation " favorisant un ralentissement progressif de la repousse des poils
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
US4269831A (en) * 1979-05-09 1981-05-26 Sterling Drug Inc. Topical dermatological method of use of an androstenopyrazole
JP2519024B2 (ja) * 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
JPS595154A (ja) * 1982-06-30 1984-01-12 Ono Pharmaceut Co Ltd プロスタグランジンｄ類似化合物
US4508714A (en) * 1983-11-14 1985-04-02 Tihomir Cecic Organic scalp lotion
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
US4935231A (en) * 1985-08-28 1990-06-19 Repligen Corporation Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
US5096911A (en) * 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE69128034T2 (de) * 1990-08-14 1998-04-16 Handelman Joseph H Enzymatische änderung des haarwuchses
US5189212A (en) * 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5095007A (en) * 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE4038693A1 (de) * 1990-12-05 1992-06-11 Heverhagen Ulrich Mittel zum reduzieren des wachstums bzw. zum entfernen der haare am menschlichen koerper
US5143925A (en) * 1990-12-20 1992-09-01 Douglas Shander Alteration of rate and character of hair growth
GB9118979D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5328686A (en) * 1991-10-30 1994-07-12 Douglas Shander Treatment of acne or of pseudofolliculitis barbae
CA2122002C (en) * 1991-11-05 1997-12-16 Gurpreet S. Ahluwalia Alteration of rate and character of hair growth
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US6743419B1 (en) * 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5648394A (en) * 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US6414017B2 (en) * 1993-05-28 2002-07-02 The Gillette Company Inhibition of hair growth
US6248751B1 (en) * 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
US6239170B1 (en) * 1993-05-28 2001-05-29 Gurpreet S. Ahluwalia Inhibition of hair growth
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5362748A (en) * 1993-09-15 1994-11-08 The Procter & Gamble Company Methods of using diethyldithiocarbamic acid for the prevention of hair growth
US5474763A (en) * 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
US5554608A (en) * 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
ATE219928T1 (de) * 1995-02-28 2002-07-15 Gillette Co Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
US5645825A (en) * 1995-06-07 1997-07-08 The Procter & Gamble Company Depilatory compositions comprising sulfhydryl compounds
US5728736A (en) * 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) * 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
US5700835A (en) * 1995-12-22 1997-12-23 Alcon Laboratories, Inc. 3-Oxa-D-prostaglandins for lowering IOP
US5908867A (en) * 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
US5840752A (en) * 1996-11-21 1998-11-24 Henry; James P. Reduction of hair growth
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US6037326A (en) * 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
US6281229B1 (en) * 1997-06-27 2001-08-28 Kaneka Corporation Heat shock factor activity inhibitors
US5939458A (en) * 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
JP3906882B2 (ja) * 1997-10-24 2007-04-18 株式会社富士通ゼネラル 永久磁石電動機
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6060471A (en) * 1998-01-21 2000-05-09 Styczynski; Peter Reduction of hair growth
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6020006A (en) * 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
US6060006A (en) * 1999-02-11 2000-05-09 Savenok; Peter Method of manufacture of synthetic stone article
US6121269A (en) * 1999-02-22 2000-09-19 Henry; James P. Reduction of hair growth
AU7995300A (en) * 1999-10-05 2001-05-10 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
US6235737B1 (en) * 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
US6299865B1 (en) * 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
US6630511B2 (en) * 2000-08-01 2003-10-07 Rolland F. Hebert Water-soluble salts of 2-difluoromethyl-2,5-diaminopentanoic acid (DFMO)
AU2001296558A1 (en) * 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
US6743822B2 (en) * 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth

Also Published As

Publication number Publication date
CN1946372B (zh) 2011-10-05
US20050249685A1 (en) 2005-11-10
CN1946372A (zh) 2007-04-11
AU2005237545B2 (en) 2008-09-18
JP2007534700A (ja) 2007-11-29
MXPA06012400A (es) 2007-01-17
US20090182031A1 (en) 2009-07-16
WO2005105023A1 (en) 2005-11-10
KR20080079699A (ko) 2008-09-01
AU2005237545A1 (en) 2005-11-10
JP4189024B2 (ja) 2008-12-03
KR20070001241A (ko) 2007-01-03
KR100891884B1 (ko) 2009-04-03
EP1750653A1 (en) 2007-02-14
CA2563193A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
BR112022011421A2 (pt) Inibidores da proteína mutante kras
BR112022024755A2 (pt) Composição, kit e método para detectar sars-cov-2 e uso dos mesmos
CR11483A (es) Inhibidores de peptido desformilasa
UY30297A1 (es) Inhibidores de la quinasa c-fms-i
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
SV2008002828A (es) Agentes para prevenir y tratar trastornos que involucran la modulacion de los receptores ryr ref. 19240-619-sv1
CL2008002775A1 (es) Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
BRPI0509150A (pt) compostos para a inibição de angiogênese e uso destes
CL2007003212A1 (es) Compuestos derivados de imidazopirazinas, inhibidores de proteina quinasa; composicion farmaceutica que los comprende; y su uso para tratar cancer.
CL2011000134A1 (es) Compuestos derivados de aminofenoxiindazoles, inhibidores de c-met; composicion farmaceutica que comprende a estos compuestos; y su uso para tratar el cancer.
HN2001000146A (es) Derivados de pirazol
BRPI0713349A2 (pt) Inibidores de proteína tirosina fosfatase humana e métodos de utilização
CL2008000873A1 (es) Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis.
CY1116377T1 (el) Αναστολεις της ανθρωπινης πρωτεϊνικης φωσφατασης της τυροσινης και μεθοδοι χρησης
CU23778B7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
ECSP088450A (es) Derivados de pirimidina 4-(3-aminopirazol) para uso como inhibidores de tirosina quinasa en el tratamiento de cáncer
UY30748A1 (es) Compuesto0s novedosos
ECSP099721A (es) Inhibidores de cinasa p70 s6
CR10213A (es) Moduladores de la proteína quinasa aurora
CL2008002478A1 (es) Compuestos derivados de n-fenil-5-(4 haloalcoxi)fenil) pirimidin-2-amino, inhibidores de c-kit y pdgfr; composicion farmaceutica; y su uso en el tratmiento de asma, dermatitis atopica, hipertension pulmonar o arterial, fibrosis renal, pulmonar o cardiaca, entre otras.
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
CL2008002041A1 (es) Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
SV2006002232A (es) Inhibidores bace ref. x-16940
CL2007002329A1 (es) Compuestos derivados de 5,6-bisaril-2-piridin carboxamida, inhibidores de urotensina ii; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar y/o prevenir insuficiencia cardiaca congestiva, is
HN2003000062A (es) Derivados de nicotinamida utiles como inhibidores de pde4

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: THE GILLETTE COMPANY (US)

Free format text: ENDERECO DO DEPOSITANTE ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110083964/RJ DE 11/08/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.